None listed
Conditions
Interventions
None listed
Sponsors
Wonkwang University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with acute coronary syndrome who have undergone successful percutaneous coronary intervention with drug-eluting stent implantation 2) Patients who voluntarily agree to participate in the study and provide written informed consent
Exclusion criteria
Exclusion criteria: 1) Age < 19 years 2) Patients who received loading treatment with clopidogrel or prasugrel prior to the index procedure 3) Contraindications to ticagrelor, including a history of intracranial hemorrhage or active bleeding 4) Patients with an expected life expectancy of less than 1 year 5) Patients deemed inappropriate for study participation at the discretion of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target vessel failure (cardiac death, target vessel myocardial infarction, target vessel revascularization) | — |
Secondary
| Measure | Time frame |
|---|---|
| Major adverse cardiovascular event (all cause death, myocardial infarction, stroke, any revascularization) | — |
Countries
Korea, Republic of
Contacts
Public ContactKyeong Ho Yun
Wonkwang University Hospital
Outcome results
None listed